Browse the latest research summaries in the field of biomedical for spinal cord injury patients and caregivers.
Showing 61-70 of 904 results
Frontiers in Pharmacology, 2024 • December 11, 2024
This study provides a bibliometric analysis of nanotechnology in SCI research, highlighting global research output, collaborative networks, and influential works. The analysis identifies China, the Un...
KEY FINDING: China and the United States are the leading countries in nanotechnology research for SCI, with China showing rapid growth in publications after 2019.
Bioactive Materials, 2025 • November 24, 2024
This study introduces novel Ejiao carbon dots (EJCDs) designed to regulate the immune system's response to spinal cord injury (SCI) by targeting the bone marrow and spleen. EJCDs promote hematopoietic...
KEY FINDING: EJCDs promote HSC self-renewal and erythroid differentiation in the bone marrow by upregulating FZD4 protein expression in LSK cells.
Journal of Nanobiotechnology, 2025 • January 1, 2025
This study investigates the effects of Apelin-13, delivered via a ROS-responsive hydrogel, on macrophage polarization and neuroinflammation in a rat model of spinal cord injury (SCI). The hydrogel was...
KEY FINDING: Apelin-13 is significantly downregulated in the injured sites of the SCI model rats since day 14 after modeling.
Journal of Nanobiotechnology, 2025 • January 1, 2025
This study synthesized ultra-small LNT-UsSeNPs, demonstrating improved therapeutic effects against SCI due to enhanced structural design and surface modifications with LNT to improve stability and cel...
KEY FINDING: LNT-UsSeNPs exhibit superior ROS scavenging capabilities compared to conventional LNT-SeNPs, protecting PC-12 cells from oxidative stress-induced cytotoxicity and alleviating mitochondrial dysfunction.
Journal of Tissue Engineering, 2025 • January 8, 2025
This study explores the potential of umbilical cord mesenchymal stem cells (UCMSCs) in treating rotator cuff tendon injuries, which often lead to shoulder pain and dysfunction. The research identifies...
KEY FINDING: CTGF was found to be the most effective growth factor for inducing the differentiation of UCMSCs into tendon cells, leading to changes in cell morphology and increased expression of tendon-specific proteins.
Materials Today Bio, 2025 • January 7, 2025
The study developed an injectable hydrogel (OPDL gel) for treating spinal cord injuries and providing wound care. The hydrogel encapsulates dexamethasone (Dex) and responds to reactive oxygen species ...
KEY FINDING: The OPDL gel demonstrated excellent injectability and self-healing properties, allowing its precise application at the site of spinal cord injury by using a syringe for effective care delivery.
Journal of Neural Engineering, 2025 • February 14, 2025
This study investigates the potential of electromagnetic stimulation to restore axonal conductance in locally demyelinated axons using a computational model. Results indicate that microcoil stimulatio...
KEY FINDING: Subthreshold microcoil stimulation depolarized node membranes, enhancing activation and restoring axonal conductance in demyelinated regions.
Frontiers in Bioengineering and Biotechnology, 2023 • August 16, 2023
This review summarizes the progress of lipid nanovesicles for targeted treatment of SCI, discusses their advantages and challenges, and provides a perspective on their application. Most lipid nanovesi...
KEY FINDING: Lipid nanovesicles, including liposomes and extracellular vesicles, can be modified to enhance their ability to target specific cells and tissues in the spinal cord.
Theranostics, 2025 • January 27, 2025
The study successfully synthesized NABDM using coaxial electrospinning technology, creating core-shell structured nano-fiber/nets. This structure ensures time-specific drug release and improves mechan...
KEY FINDING: NABDM modifies the polarization direction of microglia in vitro, and promotes the differentiation of NSCs by activating the cGMP–PKG and cAMP signaling pathways.
Frontiers in Pharmacology, 2025 • February 14, 2025
This study investigated the effects of Rosa canina oligosaccharide liposomal formulation (Oligo-L) on sensory-motor function, following SCI in rats. The findings indicated that Oligo-L treatment led t...
KEY FINDING: Oligo-L treatment significantly improved neuropathic pain and motor function performance in rats with SCI from the first week post-injury.